Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy “In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ...

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...

AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients DUBLIN, July 28, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and ...

Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it received FDA clearance and a CE mark for its insertable cardiac monitor with remote ...

MOBILE, Ala. (WALA) -The FDA recently expanded use for the LINQ II™ insertable cardiac monitor (ICM) to patients ages 2 years and older who have heart rhythm issues. About one-third the size of a AAA ...

AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM MedTech Breakthrough, an independent market intelligence organization ...

Medtronic has its heart set on ensuring that its insertable cardiac monitors are as accurate as possible, and a new pair of artificial intelligence algorithms might be just the ticket. The AccuRhythm ...